Medpace Holdings, Inc. (MEDP)
Services-Commercial Physical & Biological Research
Latest Price
$595.41
TTM P/E
34.94
Normalized P/E
53.92
Div Yield
--
Book Value
15.33
P/B Ratio
38.85
Valuation metrics
adjust assumptions →EPS: $15.28
Book value / share: $16.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$74.59
87% downside
Norm. op. income: $279M (median of 7yr)
Tax rate: 15%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$100.99
83% downside
Base FCF: $397M (median of recent 5yr)
Growth: 21%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$817.48
+37% upside
EPS: $15.28
Target P/E: 54×
Formula: EPS × P/E
P/E Fair Value
$825.12
+39% upside
Institutional Ownership
85.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.50M | $1.32B | 8.95% | +27.8K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.07M | $1.10B | 7.42% | +1.78M | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 1.28M | $677.0M | 4.58% | -74.9K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.13M | $600.0M | 4.06% | +11.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.03M | $543.0M | 3.68% | +15.7K | 2026-06-30 |
| STATE STREET CORP | 710.9K | $376.0M | 2.55% | +28.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 710.5K | $376.0M | 2.55% | -34.6K | 2026-06-30 |
| WASATCH ADVISORS LP | 636.6K | $337.0M | 2.28% | -137.3K | 2026-06-30 |
| Invesco Ltd. | 579.2K | $306.0M | 2.08% | +1.7K | 2026-06-30 |
| BAILLIE GIFFORD & CO | 473.2K | $250.0M | 1.70% | -30.0K | 2026-06-30 |